Skip to main content
. 2021 Mar 8;11:5438. doi: 10.1038/s41598-021-84953-9

Figure 3.

Figure 3

Progression-free survival for patients with overexpressed mRNA candidates. Survival curve shows that “high risk” (all overexpressed candidates) group have an overall shorter time to recurrence outcome compared to “low risk” (at least one candidate downregulated) in OC patients. P value is presented above.